awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q52668213-7C3D6395-1D08-43F0-8519-D9E498D58058
Q52668213-7C3D6395-1D08-43F0-8519-D9E498D58058
BestRank
Statement
http://www.wikidata.org/entity/statement/Q52668213-7C3D6395-1D08-43F0-8519-D9E498D58058
Polo-like kinase inhibitor volasertib marginally enhances the efficacy of the novel Fc-engineered anti-CD33 antibody BI 836858 in acute myeloid leukemia.
P2860
Q52668213-7C3D6395-1D08-43F0-8519-D9E498D58058
BestRank
Statement
http://www.wikidata.org/entity/statement/Q52668213-7C3D6395-1D08-43F0-8519-D9E498D58058
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
2d3c5c3d8943eb95363272f0bf5d0a1c7b17b242
P2860
Correlation of CD33 expression level with disease characteristics and response to gemtuzumab ozogamicin containing chemotherapy in childhood AML.